[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100654402":3},{"organization":4,"outcomesModule":7,"designInfo":35,"detailedDescription":34,"studyPopulation":34,"armGroups":43,"interventions":56,"overallOfficials":34,"centralContacts":65,"locations":34,"responsibleParty":74,"collaborators":78,"id":83,"slug":84,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":90,"sex":91,"minAge":92,"maxAge":93,"enrollmentInfo":94,"targetDuration":34,"studyType":97,"phases":98,"briefSummary":100,"conditions":101,"keywords":108,"overallStatus":113,"whyStopped":34,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":34},{"fullName":5,"class":6},"Teesside University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":34},[9],{"measure":10,"description":11,"timeFrame":12},"Service Satisfaction Scale","A five item scale that can be used to assess and measure satisfaction, acceptability and quality of the intervention. Higher score denote positive outcomes and acceptability. Lower score denotes poor satisfaction and acceptability.","At the end of intervention (day 2)",[14,18,22,25,28,31],{"measure":15,"description":16,"timeFrame":17},"Generalised Anxiety Disorder (GAD-7)","The GAD-7 is a seven item scale for screening, measuring and assessing the severity of generalised anxiety disorder. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.","Baseline (day 1) and at the end of intervention (day 2)]",{"measure":19,"description":20,"timeFrame":21},"Oslo Social Support Scale (OSSS-3)","The scale is a 3-item self-reported measure designed for assessing and measuring the level of social support. The sum score ranges from 3 to 14, with high values representing strong levels and low values representing poor levels of social support as indicated as follows: a) 3-8 poor social support, b) 9-11 moderate social support, c) 12-14 strong social support.","Baseline (day 1) and at the end of intervention (day 2)",{"measure":23,"description":24,"timeFrame":21},"European Quality of Life Scale EQ-5D-5L","The EQ-5D-5L is a 5 item scale designed to aid assessment of the generic quality of life. In the EQ-5D-5L, each dimension has five response levels: no problems (Level 1); slight (Level 2); moderate (Level 3); severe (Level 4); and extreme problems (Level 5). There are 3,125 possible health states defined by combining one level from each dimension, ranging from 11111 (full health) to 55555 (worst health).",{"measure":26,"description":27,"timeFrame":17},"Knowledge of prostate cancer and screening scale","14 item scale that measures knowledge of Prostate Cancer (PC). The 14 items on the PC knowledge scale is scored according to whether or not the participants responded correctly to each question, and the total number of correct responses will be calculated ranging from 0 to 14, with higher scores indicating higher PC knowledge.",{"measure":29,"description":30,"timeFrame":21},"Beliefs around prostate cancer and screening intention scale","A 5-item scale that measure beliefs around prostate cancer and intention to engage in screening. Score range from 0-25 with lower score denoting strong willingness to engage in early screening uptake.",{"measure":32,"description":33,"timeFrame":21},"Intention to test for prostate cancer scale","The scale assesses the intention to take a PSA test among men when this test is: (i) offered by a doctor or (ii) based on the men's own initiative. It also predicts which attitudes (beliefs, outcomes), subjective norms (opinions of significant others, own motivation) and perceived control (obstacles, facilitating factors) are the most important for taking a PSA test. Lower total scores mean a stronger and more determined intention to undergo prostate cancer screening. Higher scores indicate low or absent readiness to complete the test.",null,{"allocation":36,"interventionModel":37,"interventionModelDescription":34,"primaryPurpose":38,"observationalModel":34,"timePerspective":34,"maskingInfo":39},"RANDOMIZED","PARALLEL","PREVENTION",{"masking":40,"maskingDescription":34,"whoMasked":41},"SINGLE",[42],"PARTICIPANT",[44,50],{"label":45,"type":46,"description":47,"interventionNames":48},"proState Cancer awareness education to pRomote Early screENing uptake (SCREEN)","EXPERIMENTAL","2 hour worksop session to foster awareness and encourage screening uptake",[49],"Behavioral: proState Cancer awareness education to pRomote Early screENing uptake",{"label":51,"type":52,"description":53,"interventionNames":54},"Control group","ACTIVE_COMPARATOR","The control group will receive intervention as usual. This may be in the form of existing prostate cancer screening information provided in hospitals, media and health centres.",[55],"Other: Control group",[57,62],{"type":58,"name":59,"description":60,"armGroupLabels":61,"otherNames":34},"BEHAVIORAL","proState Cancer awareness education to pRomote Early screENing uptake","The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours.",[45],{"type":6,"name":51,"description":63,"armGroupLabels":64,"otherNames":34},"Existing information provided by health care provider, including media around prostate cancer.",[51],[66,71],{"name":67,"role":68,"phone":69,"phoneExt":34,"email":70},"Tarela J Ike, Dr","CONTACT","0164234231","T.ike@tees.ac.uk",{"name":72,"role":68,"phone":34,"phoneExt":34,"email":73},"Dung E Jidong, PhD","Dung.jidong@manchester.ac.uk",{"type":75,"investigatorFullName":76,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":34,"oldOrganization":34},"PRINCIPAL_INVESTIGATOR","Tarela Ike","Senior Lecturer",[79,81],{"name":80,"class":6},"Jos University Teaching Hospital",{"name":82,"class":6},"University of Manchester","100654402","prostate-cancer-health-education-to-promote-early-sreening-uptake-screen-a-pilot-randomised-control-trial-100654402",false,"NCT07800390","proState Cancer Health Education to pRomote Early sreENing Uptake (SCREEN): A Pilot Randomised Control Trial","SCREEN","Inclusion Criteria:\n\n* Men aged between age 18 years and 79 who are not or partially up to date with prostate cancer\n* Able to provide full consent for their participation.\n* Able to speak the English Language. Able to take part in the intervention and are available for the intervention assessment at baseline and end of intervention.\n\nExclusion Criteria:\n\n* Less than 18 years\n* Unable to consent.\n* Currently undergoing severe mental health treatment.\n* Unable to speak the English language\n* not meeting the inclusion criteria.",true,"MALE","18 Years","70 Years",{"count":95,"type":96},74,"ESTIMATED","INTERVENTIONAL",[99],"NA","Prostate cancer is an issue of significant public health concern. Yet in low- and middle-income countries like Nigeria, men are adversely affected due to factors including poor early prostate cancer screening uptake. Yet a gap remains in addressing this urgent problem. The proposed study seeks to pilot the feasibility and acceptability of a novel co-produced workshop intervention called \"proState Cancer awareness education to pRomote Early screENing uptake (SCREEN) with men who are not or partially up to date with their screening. The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours. The proposed study also aims to pilot and test the instrument to determine its effectiveness and cost-effectiveness, including the mechanism by which the intervention might work.",[102,103,104,105,106,107],"Anxiety","Prostate Cancer","Health Education","Screening and Brief Interventions","Screening","Wellbeing",[109,110,111,112],"Prostate cancer screening","Health education workshop","anxiety","Early screening uptake","NOT_YET_RECRUITING","2026-08-29",{"date":116,"type":117},"2026-09-02","ACTUAL",{"date":119,"type":96},"2026-09-15",{"date":121,"type":96},"2027-09-30",{"name":5,"class":6}]